Real-Time PCR (qPCR) Market Trends and Overview

The Real-Time PCR (qPCR) market size was valued at USD 5.2 billion in 2022 and is projected to reach USD 8.07 billion by 2030, with a compound annual growth rate (CAGR) of 5.65% during the forecast period from 2023 to 2030.

Real-Time PCR, also known as qPCR, is a widely adopted molecular biology technique used for the detection and quantification of DNA or RNA in real-time. This technology has gained significant importance in various fields, including clinical diagnostics, research, and pharmaceuticals.

The market for Real-Time PCR is expected to witness substantial growth over the forecast period. Factors such as the increasing prevalence of infectious diseases, rising demand for personalized medicine, and advancements in genomics research are driving the market growth. Additionally, the growing adoption of Real-Time PCR in the diagnosis of genetic disorders and cancer is further fueling the market expansion.

Furthermore, the COVID-19 pandemic has significantly boosted the demand for Real-Time PCR, as it plays a crucial role in the detection and monitoring of the virus. The need for rapid and accurate testing methods has led to a surge in the adoption of Real-Time PCR systems worldwide.

Geographically, North America currently dominates the Real-Time PCR market, owing to the presence of well-established healthcare infrastructure, increasing research activities, and a high prevalence of chronic diseases. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, primarily due to the rising healthcare expenditure, growing awareness about advanced diagnostic techniques, and increasing investments in research and development.

Key players in the Real-Time PCR market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Qiagen N.V., and Agilent Technologies, Inc., among others. These companies are focusing on strategic collaborations, product launches, and technological advancements to strengthen their market position.

In conclusion, the Real-Time PCR market is poised for significant With the increasing demand for accurate and rapid diagnostic solutions, the Real-Time PCR market is expected to witness substantial growth in the coming years.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2573

KEY MARKET SEGMENTATION:

By Application

• Clinical
• Research
• Forensics

By End User

• Hospitals &Diagnostic Centers
• Research Laboratories & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

By Product

• Reagents & Consumables
• Instruments
• Software & Services

Some of the major key players are as follows: BD, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, QIAGEN, ABL SA Group, Agilent Technologies, Inc., Analytik Jena AG, Fluidigm Corporation, Lumex Instruments, Primerdesign Ltd. and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand — Head of Business Development & Strategy,

[email protected],

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND),

Website: https://www.snsinsider.com